Yuce Biomedical Laboratory, located in Shenzhen, is a wholly-owned subsidiary of Shenzhen Yuce Biotechnology Co., Ltd., an expert in gene detection of tumor precise immunotherapy. The company's core management team has been focusing on the research of tumor precise immunotherapy since ten years ago. Based on the profound understanding and accumulation of the industry, Yukang Medical Laboratory was formally established on 20 17.
Yukang Medical Laboratory has a clinical gene amplification laboratory that meets international standards. The laboratory covers an area of 65,438+0,500 square meters, and the testing business area is 65,438+0,000 square meters. There are 15 independent rooms, including sample receiving room, sample storage center, sample preparation area, amplification area and product analysis area, which meet all functional rooms required by molecular genetics clinical specialty. Sample types include common blood samples, fresh tissue samples, paraffin-embedded tissue samples and free DNA samples in plasma. Many types of libraries can be constructed in the laboratory, including transcriptome sequencing, whole exon sequencing, whole genome sequencing, targeted capture sequencing and so on. The annual sample processing capacity can reach 50,000 copies, which makes it possible to process samples in Qualcomm. In the future, the laboratory will also apply for the construction of laboratories needed for clinical and pathological specialty of cellular immunity.
Yukang Medical Laboratory aims to provide patients with more comprehensive and accurate testing services. Not only do we use our own ABI StepOne Plus real-time fluorescence quantitative PCR platform, second-generation illumina sequencing platform and BGI sequencing platform to provide genetic testing services, but we also cooperate with many enterprises and institutions to provide non-invasive and accurate monitoring of tumor progress in a comprehensive and dynamic management way, providing patients with accurate medication guidance.